APLM — Apollomics Income Statement
0.000.00%
Last trade - 00:00
- $18.66m
- -$14.50m
2020 December 31st | 2021 December 31st | 2022 December 31st | 2023 December 31st | |
---|---|---|---|---|
Period Length: | 12 M | 12 M | 12 M | 12 M |
Source: | 20-F | 20-F | 20-F | 20-F |
Standards: | IFRS | IFRS | IFRS | IFRS |
Status: | Final | Final | Final | Final |
Total Revenue | 0 | 0 | 0 | 0 |
Selling / General / Administrative Expenses | ||||
Research And Development | ||||
Depreciation and Amortization | ||||
Unusual Expense / Income | ||||
Other Operating Expenses | ||||
Total Operating Expenses | 77.1 | 95.8 | 242 | 177 |
Operating Profit | -77.1 | -95.8 | -242 | -177 |
Total Net Non Operating Interest Income / Expense | ||||
Other Net Non Operating Costs | ||||
Net Income Before Taxes | -74.9 | -94.8 | -241 | -173 |
Provision for Income Taxes | ||||
Net Income After Taxes | -74.8 | -94.8 | -241 | -173 |
Net Income Before Extraordinary Items | ||||
Net Income | -74.8 | -94.8 | -241 | -173 |
Income Available to Common Shareholders Excluding Extraordinary Items | ||||
Income Available to Common Shareholders Including Extraordinary Items | ||||
Diluted Net Income | -74.8 | -94.8 | -241 | -173 |
Diluted Weighted Average Shares | ||||
Basic EPS Including Extraordinary Items | ||||
Diluted EPS Including Extraordinary Items | ||||
Diluted EPS Excluding Extraordinary Items | ||||
Normalised Income Before Taxes | ||||
Normalised Income After Taxes | ||||
Normalised Income Available to Common Shareholders | ||||
Diluted Normalised EPS | -0.855 | -1.07 | -2.77 | -1.93 |